Adjuvant effect enhancement of porcine interleukin-2 packaged into solid lipid nanoparticles

Research in Veterinary Science

Volumn 96, Issue 1, 2014, Pages 62-68

  Chen, Guohua ^a   Zeng, Shuang ^a   Jia, Huaijie ^a   He, Xiaobing ^a   Fang, Yongxiang ^a   Jing, Zhizhong ^a   Cai, Xuepeng ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

Adjuvant effect; Packaging; Recombinant porcine interleukine 2; Solid liquid nanoparticles

Indexed keywords

FOOT AND MOUTH DISEASE VACCINE; GAMMA INTERFERON; HYDROGENATED CASTOR OIL; INTERLEUKIN 2; INTERLEUKIN 4; POLYGLACTIN; RECOMBINANT INTERLEUKIN 2; SOLID LIPID NANOPARTICLE; SOLVENT;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; DRUG PACKAGING; DRUG RELEASE; DRUG SYNTHESIS; EMULSION; EVAPORATION; FEMALE; HUMORAL IMMUNITY; IMMUNIZATION; IN VITRO STUDY; MOUSE; NONHUMAN; SPLEEN CELL; SWINE;

ANIMALIA; FOOT-AND-MOUTH DISEASE VIRUS; MUS; SUS;

ADJUVANT EFFECT; PACKAGING; RECOMBINANT PORCINE INTERLEUKINE-2; SOLID LIQUID NANOPARTICLES;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; CELL PROLIFERATION; FEMALE; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; IMMUNIZATION; INTERLEUKIN-2; LIPIDS; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; RANDOM ALLOCATION; SWINE;

EID: 84892505660     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2013.11.017     Document Type: Article

References (29)

1. Aguilar J.C., Rodriguez E.G. Vaccine adjuvants revisited. Vaccine 2007, 25(19):3752-3762. Available from:
2. Chen G.H., Jia J.H., Zeng S., Fang Y.X., Li X.Q., Jing Z.Z., Cai X.P. Expression and bioactivity analysis of porcine IL-2 in Pichia pastoris. Chinese Journal of Animal and Veterinary Sciences 2011, 43(4):551-556.
3. Chen H.Y., Zhang H.Y., Huang Y.Q., Cui B.A., Wang Z.Y., Wang Y.B., Liu J.P., Chao A.J. Porcine interleukin-2 expression in insect cells and its enhancement of pig immunity to swine influenza virus inactivated vaccine. Agricultural Sciences in China 2010, 9(8):1211-1220. Available from: //000280653900016. doi: 10.1016/S1671-2927(09)60209-1.
4. Fulcher D., Wong S. Carboxyfluorescein succinimidyl ester-based proliferative assays for assessment of T cell function in the diagnostic laboratory. Immunology & Cell Biology 1999, 77(6):559-564. Available from:
5. Hanafusa T., Pujol-Borrell R., Chiovato L., Russell R.C., Doniach D., Bottazzo G.F. Aberrant expression of HLA-DR antigen on thyrocytes in graves' disease: relevance for autoimmunity. Lancet 1983, 2(8359):1111-1115. Available from:
6. Li S., Zhao B., Wang F., Wang M., Xie S., Wang S., Han C., Zhu L., Zhou W. Yak interferon-alpha loaded solid lipid nanoparticles for controlled release. Research in Veterinary Science 2010, 88(1):148-153. Available from:
7. Lofthouse S.A., Andrews A.E., Elhay M.J., Bowles V.M., Meeusen E.N.T., Nash A.D. Cytokines as adjuvants for ruminant vaccines. International Journal for Parasitology 1996, 26(8-9):835-842. Available from: //A1996VR27700006. doi: 10.1016/S0020-7519(96)80052-X.
8. Look M., Bandyopadhyay A., Blum J.S., Fahmy T.M. Application of nanotechnologies for improved immune response against infectious diseases in the developing world. Advanced Drug Delivery Reviews 2010, 62(4-5):378-393. Available from:
9. Lyons A.B., Parish C.R. Determination of lymphocyte division by flow cytometry. Journal of Immunological Methods 1994, 171(1):131-137. Available from:
10. Mahanta K.C. Veterinary Microbiology 1966, Asia Publishing House, London.
11. Mbawuike I.N., Wyde P.R., Anderson P.M. Enhancement of the protective efficacy of inactivated influenza a virus vaccine in aged mice by IL-2 liposomes. Vaccine 1990, 8(4):347-352. Available from:
12. Müller R.H., Mäder K., Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. European Journal of Pharmaceutics and Biopharmaceutics 2000, 50(1):161-177. Available from:
13. Nobiron I., Thompson I., Brownlie J., Collins M.E. Co-administration of IL-2 enhances antigen-specific immune responses following vaccination with DNA encoding the glycoprotein E2 of bovine viral diarrhoea virus. Veterinary Microbiology 2000, 76(2):129-142. Available from:
14. Oh Y.K., Park J.S., Kang M.J., Ko J.J., Kim J.M., Kim C.K. Enhanced adjuvanticity of interleukin-2 plasmid DNA administered in polyethylenimine complexes. Vaccine 2003, 21(21-22):2837-2843. Available from:
15. Oh Y.K., Sohn T., Park J.S., Kang M.J., Choi H.G., Kim J.A., Kim W.K., Ko J.J., Kim C.K. Enhanced mucosal and systemic immunogenicity of human papillomavirus-like particles encapsidating interleukin-2 gene adjuvant. Virology 2004, 328(2):266-273. Available from:
16. Olbrich C., Müller R.H., Tabatt K., Kayser O., Schulze C., Schade R. Stable biocompatible adjuvants - a new type of adjuvant based on solid lipid nanoparticles: a study on cytotoxicity, compatibility and efficacy in chicken. Alternatives To Laboratory Animals 2002, 30(4):443-458. Available from:
17. Petrovsky N., Aguilar J.C. Vaccine adjuvants: current state and future trends. Immunology & Cell Biology 2004, 82(5):488-496. Available from:
18. Popma S.H., Krasinskas A.M., McLean A.D., Szeto W.Y., Kreisel D., Moore J.S., Rosengard B.R. Immune monitoring in xenotransplantation: the multiparameter flow cytometric mixed lymphocyte culture assay. Cytometry 2000, 42(5):277-283. Available from:
19. Schijns V.E., Claassen I.J., Vermeulen A.A., Horzinek M.C., Osterhaus A.D. Modulation of antiviral immune responses by exogenous cytokines: Effects of tumour necrosis factor-alpha, interleukin-1 alpha, interleukin-2 and interferon-gamma on the immunogenicity of an inactivated rabies vaccine. Journal of General Virology 1994, 75(Pt 1):55-63. Available from:
20. Shah M.A.A., Song X.K., Xu L.X., Yan R.F., Li X.R. Construction of DNA vaccines encoding Eimeria acervulina cSZ-2 with chicken IL-2 and IFN-gamma and their efficacy against poultry coccidiosis. Research in Veterinary Science 2011, 90(1):72-77. Available from: //000286994700015. doi: 10.1016/j.rvsc.2010.05.003.
21. Tarradas J., Argilaguet J.M., Rosell R., Nofrarias M., Crisci E., Cordoba L., Perez-Martin E., Diaz I., Rodriguez F., Domingo M., Montoya M., Ganges L. Interferon-gamma induction correlates with protection by DNA vaccine expressing E2 glycoprotein against classical swine fever virus infection in domestic pigs. Veterinary Microbiology 2010, 142(1-2):51-58. Available from: //000276800800009. doi: 10.1016/j.vetmic.2009.09.043.
22. Tomoda T., Morita H., Kurashige T., Maassab H.F. Prevention of influenza by the intranasal administration of cold-recombinant, live-attenuated influenza-virus vaccine - importance of interferon-gamma production and local IgA response. Vaccine 1995, 13(2):185-190. Available from://A1995QK47300009. doi: 10.1016/0264-410x(95)93134-U.
23. Tsudo M., Uchiyama T., Uchino H. Expression of Tac antigen on activated normal human B cells. Journal of Experimental Medicine 1984, 160(2):612-617. Available from:
24. Vincent A.L., Ciacci-Zanella J.R., Lorusso A., Gauger P.C., Zanella E.L., Kehrli M.E., Janke B.H., Lager K.M. Efficacy of inactivated swine influenza virus vaccines against the 2009 A/H1N1 influenza virus in pigs. Vaccine 2010, 28(15):2782-2787. Available from: //000276174600015. Doi: 10.1016/j.vaccine.2010.01.049.
25. Wissing S.A., Kayser O., Müller R.H. Solid lipid nanoparticles for parenteral drug delivery. Advanced Drug Delivery Reviews 2004, 56(9):1257-1272. Available from:
26. Wyckoff J.H., Howland J.L., Scott C.M., Smith R.A., Confer A.W. Recombinant bovine interleukin 2 enhances immunity and protection induced by Brucella abortus vaccines in cattle. Veterinary Microbiology 2005, 111(1-2):77-87. Available from:
27. Xie S., Wang S., Zhao B., Han C., Wang M., Zhou W. Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles. Colloids and Surfaces B: Biointerfaces 2008, 67(2):199-204. Available from:
28. Yadav S., Sharma R., Chhabra R. Interleukin-2 potentiates foot-and-mouth disease vaccinal immune responses in mice. Vaccine 2005, 23(23):3005-3009. Available from:
29. Yang Y., Chen J., Li H., Wang Y., Xie Z., Wu M., Zhang H., Zhao Z., Chen Q., Fu M., Wu K., Chi C., Wang H., Gao R. Porcine interleukin-2 gene encapsulated in chitosan nanoparticles enhances immune response of mice to piglet paratyphoid vaccine. Comparative Immunology, Microbiology and Infectious Diseases 2007, 30(1):19-32. Available from: